Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA3 | P07451 | 2/20 | 0.50 |
| ▸ | CA4 | P22748 | 2/20 | 0.50 |
| ▸ | CA6 | P23280 | 2/20 | 0.50 |
| ▸ | CA5A | P35218 | 2/20 | 0.50 |
| ▸ | CA7 | P43166 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | ODC1 | P11926 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3996459 | 1.00 | NFKB1 (0.54) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL2050536 | 0.96 | DNM1 (0.57) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL21357594 | 0.96 | DNM1 (0.57) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL8746964 | 0.96 | DNM1 (0.57) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL1726884 | 0.96 | NFKB1 (0.50) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL24306534 | 0.96 | DNM1 (0.57) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL11236971 | 0.96 | NFKB1 (0.50) | NFKB1DNM1CA12CA1CA2 | |
| Hydrochloric Acid SCHEMBL16030749 | 0.96 | NFKB1 (0.50) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL8746941 | 0.96 | DNM1 (0.57) | NFKB1DNM1CA12CA1CA2 | |
| SCHEMBL6049174 | 0.96 | DNM1 (0.57) | NFKB1DNM1CA12CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12570890-B2 | Additives for well treatment, methods for preparing well treatment composition using these additives, and applications of said composition | CAMERON INTERNATIONAL CORPORATION (US) | 2026-03-10 | — | — | US | claimed |
| US-20250297153-A1 | ADDITIVES FOR WELL TREATMENT, METHODS FOR PREPARING WELL TREATMENT COMPOSITION USING THESE ADDITIVES, AND APPLICATIONS OF SAID COMPOSITION | CAMERON INTERNATIONAL CORPORATION | 2025-09-25 | — | — | US | claimed |
| EP-4526395-A1 | ADDITIVES FOR WELL TREATMENT, METHODS FOR PREPARING WELL TREATMENT COMPOSITION USING THESE ADDITIVES, AND APPLICATIONS OF SAID COMPOSITION | Cameron Technologies Limited (NL) | 2025-03-26 | — | — | EP | claimed |
| CN-119256064-A | Additives for well treatment, methods of preparing well treatment compositions using these additives, and uses of the compositions | 卡梅伦技术有限公司 | 2025-01-03 | — | — | CN | claimed |
| WO-2023224967-A1 | ADDITIVES FOR WELL TREATMENT, METHODS FOR PREPARING WELL TREATMENT COMPOSITION USING THESE ADDITIVES, AND APPLICATIONS OF SAID COMPOSITION | CAMERON INTERNATIONAL CORPORATION (US) | 2023-11-23 | — | — | WO | claimed |
| US-12570890-B2 | Additives for well treatment, methods for preparing well treatment composition using these additives, and applications of said composition | CAMERON INTERNATIONAL CORPORATION (US) | 2026-03-10 | — | — | US | disclosed |
| US-12479840-B2 | HMG-CoA reductase degradation inducing compound | UPPTHERA INC. (KR) | 2025-11-25 | — | — | US | disclosed |
| US-20250297153-A1 | ADDITIVES FOR WELL TREATMENT, METHODS FOR PREPARING WELL TREATMENT COMPOSITION USING THESE ADDITIVES, AND APPLICATIONS OF SAID COMPOSITION | CAMERON INTERNATIONAL CORPORATION | 2025-09-25 | — | — | US | disclosed |
| EP-4526395-A1 | ADDITIVES FOR WELL TREATMENT, METHODS FOR PREPARING WELL TREATMENT COMPOSITION USING THESE ADDITIVES, AND APPLICATIONS OF SAID COMPOSITION | Cameron Technologies Limited (NL) | 2025-03-26 | — | — | EP | disclosed |
| CN-119256064-A | Additives for well treatment, methods of preparing well treatment compositions using these additives, and uses of the compositions | 卡梅伦技术有限公司 | 2025-01-03 | — | — | CN | disclosed |
| WO-2023224967-A1 | ADDITIVES FOR WELL TREATMENT, METHODS FOR PREPARING WELL TREATMENT COMPOSITION USING THESE ADDITIVES, AND APPLICATIONS OF SAID COMPOSITION | CAMERON INTERNATIONAL CORPORATION (US) | 2023-11-23 | — | — | WO | disclosed |
| EP-4279494-A1 | METHOD FOR DECOMPOSING COMPOUND, AND COMPOUND | National University Corporation Hokkaido University (JP) | 2023-11-22 | — | — | EP | disclosed |
| EP-0042940-B1 | HETEROALKYLENE-BIS-ANTHRAQUINONES | AMERICAN CYANAMID COMPANY (US) | 1984-06-06 | — | — | EP | disclosed |
| EP-0030822-B1 | SYNTHETIC ABSORBABLE SURGICAL DEVICES OF POLYESTER AMIDES AND PROCESS FOR MAKING THEM | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1983-09-14 | — | — | EP | disclosed |
| EP-0078436-A1 | Non-crystalline polyamine/carbonic-acid salt compostions, process for their preparation and their use in making polyurethane-polyureas, particularly foamed coatings | BAYER AG (DE) | 1983-05-11 | — | — | EP | disclosed |
| US-4343931-A | FILAMENTS, SUTURES, PROSTHETICS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1982-08-10 | — | — | US | disclosed |
| EP-0042940-A1 | Heteroalkylene-bis-anthraquinones | AMERICAN CYANAMID COMPANY (US) | 1982-01-06 | — | — | EP | disclosed |
| US-4278605-A | ANTITUMOR AGENTS | AMERICAN CYANAMID COMPANY (US) | 1981-07-14 | — | — | US | disclosed |
| EP-0030822-A2 | Synthetic absorbable surgical devices of polyester amides and process for making them | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1981-06-24 | — | — | EP | disclosed |
| US-3994882-A | ANTIMICROBIAL | KABUSHIKI KAISHA UENO SEIYAKU OYO KENKYUJO (JA) | 1976-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12570890-B2 | Additives for well treatment, methods for preparing well treatment composition using these additives, and applications of said composition | ATM, PWWP2B, AQP3 | NFKB1 3127/4885DNM1 4872/4885CA12 1524/4885 |
| US-12479840-B2 | HMG-CoA reductase degradation inducing compound | HMGCR, HMGB2, LDLR | NFKB1 677/4885DNM1 1523/4885CA12 4432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.